210 related articles for article (PubMed ID: 20689568)
1. Utility of optic pathway glioma screening in young children with neurofibromatosis type I: questions generated by a clinical audit.
Pilling RF; Lloyd IC; Huson S
Eye (Lond); 2010 Oct; 24(10):1603-5. PubMed ID: 20689568
[TBL] [Abstract][Full Text] [Related]
2. Screening and diagnosis of optic pathway gliomas in children with neurofibromatosis type 1 by using sweep visual evoked potentials.
Chang BC; Mirabella G; Yagev R; Banh M; Mezer E; Parkin PC; Westall CA; Buncic JR
Invest Ophthalmol Vis Sci; 2007 Jun; 48(6):2895-902. PubMed ID: 17525226
[TBL] [Abstract][Full Text] [Related]
3. Risk of optic pathway glioma in children with neurofibromatosis type 1 and optic nerve tortuosity or nerve sheath thickening.
Levin MH; Armstrong GT; Broad JH; Zimmerman R; Bilaniuk LT; Feygin T; Li Y; Liu GT; Fisher MJ
Br J Ophthalmol; 2016 Apr; 100(4):510-4. PubMed ID: 26294105
[TBL] [Abstract][Full Text] [Related]
4. Screening for symptomatic optic pathway glioma in children with neurofibromatosis type 1.
Gutmann DH; Listernick R; Ferner RE
Eye (Lond); 2011 Jun; 25(6):818; author reply 818-9. PubMed ID: 21274014
[No Abstract] [Full Text] [Related]
5. Can screening for optic nerve gliomas in patients with neurofibromatosis type I be performed with visual-evoked potential testing?
Wolsey DH; Larson SA; Creel D; Hoffman R
J AAPOS; 2006 Aug; 10(4):307-11. PubMed ID: 16935228
[TBL] [Abstract][Full Text] [Related]
6. Optic-pathway glioma: natural history demonstrated by a new empirical score.
Schupper A; Kornreich L; Yaniv I; Cohen IJ; Shuper A
Pediatr Neurol; 2009 Jun; 40(6):432-6. PubMed ID: 19433276
[TBL] [Abstract][Full Text] [Related]
7. [Long-term outcome of gliomas of the visual pathway in type 1 neurofibromatosis].
Schröder S; Baumann-Schröder U; Hazim W; Haase W; Mautner VF
Klin Monbl Augenheilkd; 1999 Dec; 215(6):349-54. PubMed ID: 10637799
[TBL] [Abstract][Full Text] [Related]
8. Feasibility and comparison of visual acuity testing methods in children with neurofibromatosis type 1 and/or optic pathway gliomas.
Avery RA; Bouffet E; Packer RJ; Reginald A
Invest Ophthalmol Vis Sci; 2013 Feb; 54(2):1034-8. PubMed ID: 23329671
[TBL] [Abstract][Full Text] [Related]
9. Optic glioma warranting treatment in children.
Kaufman LM; Doroftei O
Eye (Lond); 2006 Oct; 20(10):1149-64. PubMed ID: 17019413
[TBL] [Abstract][Full Text] [Related]
10. Visual loss in orbitofacial neurofibromatosis type 1.
Oystreck DT; Morales J; Chaudhry I; Alorainy IA; Elkhamary SM; Pasha TM; Bosley TM
Ophthalmology; 2012 Oct; 119(10):2168-73. PubMed ID: 22709421
[TBL] [Abstract][Full Text] [Related]
11. Ophthalmological examination in neurofibromatosis type 1: a long-term retrospective analysis.
Cassiman C; Laenen A; Jacobs S; Demaerel P; Legius E; Casteels I
Acta Ophthalmol; 2018 Dec; 96(8):e1044-e1046. PubMed ID: 30259655
[No Abstract] [Full Text] [Related]
12. Neurofibromatosis type 1 and optic pathway glioma. A long-term follow-up.
Lama G; Esposito Salsano M; Grassia C; Calabrese E; Grassia MG; Bismuto R; Melone MA; Russo S; Scuotto A
Minerva Pediatr; 2007 Feb; 59(1):13-21. PubMed ID: 17301720
[TBL] [Abstract][Full Text] [Related]
13. Screening children with NF1 for optic pathway glioma--No.
Pilling RF; Taylor RH
Eye (Lond); 2010 Sep; 24(9):1432-4. PubMed ID: 20577270
[No Abstract] [Full Text] [Related]
14. Follow-up of optic pathway gliomas in children with neurofibromatosis type 1.
Kuenzle C; Weissert M; Roulet E; Bode H; Schefer S; Huisman T; Landau K; Boltshauser E
Neuropediatrics; 1994 Dec; 25(6):295-300. PubMed ID: 7770126
[TBL] [Abstract][Full Text] [Related]
15. Comparative study of the ophthalmological examinations in neurofibromatosis type 1. Proposal for a new screening algorithm.
Caen S; Cassiman C; Legius E; Casteels I
Eur J Paediatr Neurol; 2015 Jul; 19(4):415-22. PubMed ID: 25797697
[TBL] [Abstract][Full Text] [Related]
16. Screening children with NF1 for optic pathway glioma--Yes.
Simmons I; Gogi D
Eye (Lond); 2010 Sep; 24(9):1429-31. PubMed ID: 20577275
[No Abstract] [Full Text] [Related]
17. Optic pathway gliomas in patients with neurofibromatosis type 1: follow-up of 44 patients.
Segal L; Darvish-Zargar M; Dilenge ME; Ortenberg J; Polomeno RC
J AAPOS; 2010 Apr; 14(2):155-8. PubMed ID: 20451859
[TBL] [Abstract][Full Text] [Related]
18. Optic Pathway Glioma and Cerebral Focal Abnormal Signal Intensity in Patients with Neurofibromatosis Type 1: Characteristics, Treatment Choices and Follow-up in 134 Affected Individuals and a Brief Review of the Literature.
Friedrich RE; Nuding MA
Anticancer Res; 2016 Aug; 36(8):4095-121. PubMed ID: 27466519
[TBL] [Abstract][Full Text] [Related]
19. Optic pathway glioma: long-term visual outcome in children without neurofibromatosis type-1.
Campagna M; Opocher E; Viscardi E; Calderone M; Severino SM; Cermakova I; Perilongo G
Pediatr Blood Cancer; 2010 Dec; 55(6):1083-8. PubMed ID: 20979170
[TBL] [Abstract][Full Text] [Related]
20. Extensive central nervous system involvement in optic pathway gliomas in neurofibromatosis type 1.
Shaikh F; Johnston D; Michaud J; Hurteau J; Vassilyadi M; Keene D
Pediatr Blood Cancer; 2011 Oct; 57(4):688-6690. PubMed ID: 21465640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
